1-(3-chlorophenethyl)-3-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)pyrimidine-2,4,6(1H,3H,5H)-trione

ID: ALA2381027

Chembl Id: CHEMBL2381027

Max Phase: Preclinical

Molecular Formula: C22H27ClN2O3

Molecular Weight: 402.92

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H]1[C@@H](N2C(=O)CC(=O)N(CCc3cccc(Cl)c3)C2=O)C[C@H]2C[C@@H]1C2(C)C

Standard InChI:  InChI=1S/C22H27ClN2O3/c1-13-17-10-15(22(17,2)3)11-18(13)25-20(27)12-19(26)24(21(25)28)8-7-14-5-4-6-16(23)9-14/h4-6,9,13,15,17-18H,7-8,10-12H2,1-3H3/t13-,15+,17-,18-/m0/s1

Standard InChI Key:  GQKLSSZFSJGFQZ-DHXZDTOLSA-N

Alternative Forms

  1. Parent:

    ALA2381027

    ---

Associated Targets(non-human)

CACNA1C Voltage-gated L-type calcium channel alpha-1C subunit (335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1d Voltage-gated L-type calcium channel alpha-1D subunit (336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.92Molecular Weight (Monoisotopic): 402.1710AlogP: 4.13#Rotatable Bonds: 4
Polar Surface Area: 57.69Molecular Species: ACIDHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: 5.00CX Basic pKa: CX LogP: 4.21CX LogD: 1.88
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -0.29

References

1. Kang S, Cooper G, Dunne SF, Luan CH, Surmeier DJ, Silverman RB..  (2013)  Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.,  56  (11): [PMID:23651412] [10.1021/jm4005048]

Source